Stories by Robin Carhart-Harris

Robin Carhart-Harris has overseen a series of brain imaging studies into the brain effects of LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression. He currently heads of Psychedelic Research Group at Imperial and as of November 1, 2018 will be Associate Professor at the University of Oxford, leading a new Centre for Psychedelic Research there.